Spencer S. Eccles Health Sciences Library, University of Utah
Abstract
In adults, the spectrum of MOG antibody-associated demyelinating diseases(MOG-SD) constitutes a recently described and challenging entity. It encompasses almost 25% of patients with neuro-myelitis optica spectrum disorder being negative for antiaquaporine 4 antibodies(AQP4). The most frequently observed manifestation is optic neuritis(ON), more rarely myelitis. From the first publications, demographics and clinical presentation of these patients appeared different from those with AQP4-Abs
